Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Edgewise Therapeutics Inc. EWTX

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.


Top institutional share ownership of Edgewise Therapeutics, Inc.

Name Shares Shares % change Value Value % change
Orbimed Advisors Llc 14,082,680 1.0% $112,098 -17.1%
Novo Holdings A/S 5,587,207 0.0% $44,474 -17.9%
Deerfield Management Company, L.p. (series C) 3,933,137 0.0% $31,308 -17.9%
Cormorant Asset Management, LP 3,850,000 -17.8% $30,646 -32.5%
Fmr Llc 2,815,284 11.7% $22,410 -8.4%
Viking Global Investors Lp 2,727,249 0.0% $21,709 -17.9%
Citadel Advisors Llc 2,538,018 -3.9% $20,202 -21.1%
EcoR1 Capital, LLC 2,359,808 0.0% $18,784 -17.9%
BlackRock Inc. 2,053,568 -0.1% $16,347 -18.0%
Janus Henderson Group Plc 1,609,362 12.3% $12,813 -7.8%

Top institutional buyers of Edgewise Therapeutics, Inc.

Name Shares % change Value % change Shares Value
Woodline Partners LP 114.3% 75.9% 771,797 $6,144
DAFNA Capital Management LLC 95.1% 60.1% 695,959 $5,540
FBTAX - Fidelity Advisor Biotechnology Fund Class A 55.5% 88.5% 931,400 $9,007
Opaleye Management Inc. 49.0% 22.3% 451,400 $3,593
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 16.0% -4.8% 910,498 $7,248
Janus Henderson Group Plc 12.3% -7.8% 1,609,362 $12,813
Fmr Llc 11.7% -8.4% 2,815,284 $22,410
Vanguard Group Inc 1.3% -16.9% 1,226,568 $9,763
Orbimed Advisors Llc 1.0% -17.1% 14,082,680 $112,098

Top institutional sellers of Edgewise Therapeutics, Inc.

Name Shares % change Value % change Shares Value
Cormorant Asset Management, LP -17.8% -32.5% 3,850,000 $30,646
Geode Capital Management, Llc -9.4% -25.7% 396,830 $3,158
IWM - iShares Russell 2000 ETF -8.4% -24.8% 784,305 $6,243
State Street Corp -7.0% -23.7% 524,724 $4,177
Citadel Advisors Llc -3.9% -21.1% 2,538,018 $20,202
FSOPX - Fidelity Series Small Cap Opportunities Fund -1.9% -42.5% 684,800 $6,622
JAGLX - Janus Henderson Global Life Sciences Fund Class T -1.7% -19.3% 412,550 $3,284
FCPGX - Fidelity Small Cap Growth Fund -0.5% 20.6% 797,917 $7,716
BlackRock Inc. -0.1% -18.0% 2,053,568 $16,347

Information provided by Fintel.io